GlaxoSmithKline Returns to Profit

July 26, 2011
Company earned $1.814 billion in Q2

Drugmaker GlaxoSmithKline posted net profit of more than £1.1 billion in the second quarter following a loss during the equivalent three-month period in 2010.

GSK said that earnings after tax stood at £1.106 billion (US$1.814 billion) in the quarter ending June 30 compared with a net loss of £304 million in the second quarter last year.

The company had fallen into a loss a year ago owing to exceptional legal charges linked to its former diabetes drug Avandia, which has been pulled from European shelves on fears that it increased the risk of heart attack and strokes.

"We have had a strong second quarter," said GSK chief executive Andrew Witty.

"Going forward, we continue to apply sustained pressure to GSK's cost base to realize further savings, through improvements in areas such as support functions, supply chain and procurement efficiency."

GSK was rocked last September when the EU medicines regulator decided to pull Avandia off the shelves. Regulators also restricted its availability in the United States. The EU decided to pull Avandia owing to concerns over its active substance rosiglitazone. It decided also to halt the sale of Glaxo's other diabetes drugs, Avandamet and Avaglim, since they too contained rosiglitazone.

Meanwhile sales of GSK's herpes treatment Valtrex have been hit by generic competition.

Copyright Agence France-Presse, 2011

See Also

Popular Sponsored Recommendations

Empowering the Modern Workforce: The Power of Connected Worker Technologies

March 1, 2024
Explore real-world strategies to boost worker safety, collaboration, training, and productivity in manufacturing. Emphasizing Industry 4.0, we'll discuss digitalization and automation...

3 Best Practices to Create a Product-Centric Competitive Advantage with PRO.FILE PLM

Jan. 25, 2024
Gain insight on best practices and strategies you need to accelerate engineering change management and reduce time to market. Register now for your opportunity to accelerate your...

Transformative Capabilities for XaaS Models in Manufacturing

Feb. 14, 2024
The manufacturing sector is undergoing a pivotal shift toward "servitization," or enhancing product offerings with services and embracing a subscription model. This transition...

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!